Exelixis (EXEL) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
22 hours ago • Google News
Exelixis Inc (EXEL)
US$ 44.69-1.56%
Price Chart
Key Statistics
Market Cap
$ 12.19B
P/E Ratio
20.41
Revenue (TTM)
$ 2.3B
Volume
3.49M
52W High
$ 48.85
52W Low
$ 20.14
Dividend Yield
0.00%
Beta
0.25
Technicals
50-Day MA
37.4144
200-Day MA
32.8495
52 Week High
48.85
52 Week Low
20.14
About EXEL
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
Employees
1147
Headquarters
Alameda, CA
CEO
Dr. Stelios Papadopoulos Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg